Pulmonary disease and antipyrine clearance

Area of Science:

• Pharmacology
• Pulmonology
• Hepatology

Background:

• Alpha-1-antitrypsin deficiency is a genetic disorder that can lead to chronic pulmonary disease.
• Hepatic microsomal enzymes play a role in drug metabolism.
• Antipyrine clearance is a common test to assess hepatic microsomal enzyme activity.

Purpose of the Study:

• To investigate hepatic microsomal enzyme activity in patients with alpha-1-antitrypsin deficiency and chronic pulmonary disease.
• To compare antipyrine clearance in patients with chronic pulmonary disease to healthy controls.
• To determine if lung function impairment affects antipyrine clearance.

Main Methods:

• A one-sample saliva test was used to determine antipyrine clearance.
• The study included 35 outpatients with homozygous alpha-1-antitrypsin deficiency and chronic pulmonary disease.
• Control groups consisted of 25 outpatients with chronic obstructive lung disease and 31 healthy volunteers.

Main Results:

• Antipyrine clearance did not differ significantly between the two groups of patients with pulmonary disease.
• Antipyrine clearance was 18% lower in patients with pulmonary disease compared to healthy volunteers (P < 0.01).
• Antipyrine clearance was lowest in patients with severe lung function impairment (P < 0.01).

Conclusions:

• Patients with chronic pulmonary disease exhibit reduced hepatic microsomal enzyme activity.
• Lung function impairment is associated with decreased antipyrine clearance.
• Antipyrine clearance may serve as a biomarker for hepatic enzyme function in pulmonary disease.